Denmark · Biotechnology startup
Denmark · Dancann Pharma
Dancann Pharma manufactures medical cannabis and develops novel cannabinoid therapeutics for a broad range of diseases.
Funding reportedLast round: Post ipo equity
Follow Dancann Pharma and see its new rounds in your feed.Start following
What company datasets say Dancann Pharma raised
Funding, as reported
Reported in all35.6Min the source's currency
Rounds5
Last roundPost ipo equity
Last round dateJun 2024
Investors listed1
On a portfolio page
Investors who name them
Each firm lists Dancann Pharma on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in Denmark
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Dancann Pharma in front of investors. Or tell us what we have wrong.